Bob Smith

Bob Smith joined the Foundation in early 2024 as Executive Director. He oversees the gene therapy, cancer immunotherapy, neurodegenerative diseases, veterinary medicine, and FUS Partners programs. He has more than 35 years of experience in a variety of alliance management, business development, commercial, corporate, mergers and acquisitions, and research and development roles. He was most recently senior vice president of the Global Gene Therapy Business at Pfizer, Inc. In this role, he led the company’s gene therapy and rare disease pipeline portfolio from a strategic development and operational implementation perspective as well as Pfizer’s end-to-end efforts to be an industry leader in gene therapy.